Latest filing published 29 Sept 2022 for Reckitt Benckiser Group plc, €17k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Elane Stock and Andrew Sullivan: trading record in brief
Elane Stock and Andrew Sullivan is a declared insider of Reckitt Benckiser Group plc, with filings sourced from RNS (LSE). Over a trading history stretching from 27 May 2020 to 28 September 2022, the count stands at 3 filings.
Purchases make up the whole of the open-market record (3 purchases, €47k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €16k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 29 September 2022, reports an open-market purchase of €17k in Reckitt Benckiser Group plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. The regulation allows three business days to notify a trade (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Elane Stock and Andrew Sullivan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 245 shares@ £60.6835.4% of flowLondon Stock Exchange, Main Market - XLONISIN GB00B24CGK77FCA-NSM:4527643-6Canonical exit: 27 Dec 2022 (T+90)
- 241 shares@ £57.05534.4% of flowLondon Stock Exchange, Main Market - XLONISIN GB00B24CGK77FCA-NSM:4059826-2Canonical exit: 25 Oct 2021 (T+90)
- 185 shares@ £68.7430.2% of flowLondon Stock Exchange, Main Market - XLONISIN GB00B24CGK77FCA-NSM:3608920-0Canonical exit: 25 Aug 2020 (T+90)
3 of 3 declarations